🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating how ruxolitinib affects premalignant breast cells....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-05-13
Trial ID
NCT02928978
Treatments Being Tested
This was to determine the efficacy, based upon overall survival, of ruxolit...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02119663
Treatments Being Tested
The primary objective of this study was to collect additional safety of INC...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08-16
Trial ID
NCT01493414
Treatments Being Tested
Haploidentical hematopoietic stem cell transplantation irrespective of the ...
Status
Recruiting
Location
RM Gorbacheva Research Institute
Start Date
2024-06-21
Trial ID
NCT06477549
Treatments Being Tested
A protocol named as "HLH-DR" for patients with refractory and secondary hem...
Status
Unknown
Location
Yan Yue
Start Date
2017-03-01
Trial ID
NCT03795909
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of Ruxoli...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2020-09-01
Trial ID
NCT04582604
Treatments Being Tested
9-ING-41 has anti-cancer clinical activity while not causing myelosuppressi...
Status
Completed
Location
University of Southern California
Start Date
2020-08-20
Trial ID
NCT04218071
Treatments Being Tested
Our study aimed to determine the prophylactic value of ruxolitinib for aGVH...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05914714
Treatments Being Tested
Patients with mild and severe coronavirus disease 2019 (COVID 19) will be r...
Status
Completed
Location
Lomonosov Moscow State University Medical Research and Educational Center
Start Date
2020-05-08
Trial ID
NCT04403243
To provide ruxolitinib through an expanded access program for the treatment...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04355793
Treatments Being Tested